BIIB
BIOGEN INC.
NASDAQ · Healthcare · Drug Manufacturers - General · US
$240.98
−0.87%Leverage
- Debt / equity
- 0.44x
- Net debt / equity
- 0.38x
- Debt / assets
- 0.26x
- Debt / EBITDA
- 4.27x
- Net debt / EBITDA
- 3.61x
Liquidity & coverage
- Current ratio
- 1.87x
- Quick ratio
- 1.26x
- Cash ratio
- 0.33x
- Interest coverage
- 4.47x
- EBITDA / interest
- 6.87x
- Working capital
- $3.4B
Cash & dividend
- FCF / debt
- 0.36x
- Cash flow / debt
- 0.34x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026